StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Form ARS BridgeBio Pharma, Inc. For: Dec 31
April 24, 2026 4:26 PM
ATTACHMENTS / EXHIBITS
ARS
Categories
SEC Filings
Next Articles
Raymond James on BridgeBio Pharma (BBIO): 'We expect continued strong commercial momentum for Attruby'
April 28, 2026 2:00 PM
TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now'
April 28, 2026 11:46 AM
Mizuho on BridgeBio Pharma (BBIO): 'Not Best Case but Still Good Outcome Relative to Street'
April 28, 2026 11:25 AM
Mizuho: 'BBIO could potentially trade in the $90-110+ range today / near-term'
April 28, 2026 9:48 AM
